Retatrutide Starter Kit (10mg vial)
Everything for a first retatrutide vial: 10mg vial, 30 mL bacteriostatic water, syringes and swabs.
$167.99
Kits
Retatrutide Pen Kit (20mg)
20mg premixed retatrutide pen with twenty pen needles and swabs. In Stock
$295.99AUD, GST inclusive · parts $301.38 separately, save $5.39
3 itemsWater needed: noneSave 2%CoA on requestSame business day dispatch*
What is in the kit
| Item | Qty | What it is |
|---|---|---|
| Retatrutide Pen (20mg) | ×1 | Triple GLP-1, GIP and glucagon receptor agonist; premixed 3 mL pen, 0.5 mg per click |
| Pen needles (32G 4 mm) | ×20 | 32G 4 mm universal screw-fit, 20 pack |
| Alcohol swabs | ×20 | 70% isopropyl, individually wrapped, 100 pack |
Why this kit
Twenty pen needles cover the 40 clicks of the 20mg pen at any plausible draw count.
Kit value
Bought separately the 3 items come to $301.38. The kit is $295.99, which saves $5.39 (2%). Every item is the same product sold on its own page, from the same Australian stock, with a certificate of analysis available for each peptide batch.
Preparing the kit
- Dial the 20mg pen. Nothing to mix: the pen is premixed at 6.67 mg/mL. Fit a fresh 32G pen needle, prime, and dial in 0.5 mg clicks; the click calculator on the pen page converts milligrams to clicks.
- Draw and swab. Swab the vial stopper before each draw. Use a fresh U-100 syringe each time; the calculator converts the amount in milligrams to syringe units at the concentration prepared.
- Store. Lyophilised vials at −20 °C until reconstitution. Reconstituted solution and pens at 2–8 °C, never frozen; reconstituted vials are used within 8–12 weeks, opened bacteriostatic water within 28 days.
About Retatrutide
Retatrutide
Triple GLP-1, GIP and glucagon receptor agonist
Retatrutide is a single synthetic peptide that activates three receptors at once: GLP-1, GIP and glucagon. That combination is what separates it from the earlier incretin compounds, which act on one receptor (semaglutide) or two (tirzepatide). It was developed by Eli Lilly and is still in Phase 3 clinical trials, so the only form that exists is research material like this vial.
The Phase 2 obesity trial (Jastreboff et al., NEJM 2023) reported mean body-weight reductions of up to 24.2% at 48 weeks in the highest-dose arm, with improvements in waist circumference, blood pressure and lipids. A companion Phase 2 study in type 2 diabetes reported HbA1c reductions alongside weight loss. Phase 3 (the TRIUMPH program) is ongoing; no regulator has approved retatrutide for any use.
Retatrutide in Australia: sizes, research summary and legal status →
Certificate of analysis. Every peptide in the kit comes from a batch with a certificate from an independent laboratory. Request the certificate for your batch with your order number.
Specifications
- Kit
- Retatrutide Pen Kit (20mg)
- Items
- 3 (Retatrutide Pen (20mg) ×1, Pen needles ×20, Alcohol swabs ×20)
- Compound
- Retatrutide
- CAS (Retatrutide)
- 2381089-83-2
- Water needed
- none
- Certificate of analysis
- Available on request for every peptide batch in the kit
- Storage
- Vials −20 °C lyophilised, 2–8 °C reconstituted; pens 2–8 °C; water and syringes at room temperature
- Parts bought separately
- $301.38
- Kit price
- $295.99
- SKU
- KIT-RETA-P20
For in-vitro research and laboratory use only. Not for human or veterinary use. By purchasing you confirm you are a qualified researcher and will use these products in accordance with all applicable laws.
Frequently asked questions
What is in the kit?
Retatrutide Pen (20mg) ×1; Pen needles (32G 4 mm) ×20; Alcohol swabs ×20. Every item is listed in the table above with a link to its own page.
Why these quantities?
Twenty pen needles cover the 40 clicks of the 20mg pen at any plausible draw count.
How much does the kit save?
Bought separately the parts come to $301.38; the kit is $295.99, a saving of $5.39 (2%). Kits are priced with the peptide at full price and the supplies at half price.
What does the research show about Retatrutide?
The Phase 2 obesity trial (Jastreboff et al., NEJM 2023) reported mean body-weight reductions of up to 24.2% at 48 weeks in the highest-dose arm, with improvements in waist circumference, blood pressure and lipids. A companion Phase 2 study in type 2 diabetes reported HbA1c reductions alongside weight loss. Phase 3 (the TRIUMPH program) is ongoing; no regulator has approved retatrutide for any use.
Does the kit need anything else?
No. It holds the peptide, the water or pen needles it needs, syringes where the format uses them, and swabs. A sharps container is an optional add-on.
How is it reconstituted and stored?
Water needed: none. Vials are reconstituted as described in the preparation steps above and in the reconstitution guide; lyophilised vials store at −20 °C, reconstituted solution and pens at 2–8 °C.
Is the kit for research only?
Retatrutide is an investigational drug with no marketing approval in any country, including Australia. It cannot be prescribed, dispensed or compounded for human use here. Peptide Aus supplies research-grade retatrutide for in-vitro laboratory study only; the buyer is responsible for lawful use.
Where can I buy it?
Directly from Peptide Aus, from Australian stock. Paid orders before 2pm AEST/AEDT dispatch the same business day, tracked.
Other kits with Retatrutide
Retatrutide Starter Kit (20mg vial)
The 20mg retatrutide vial with bacteriostatic water, twenty syringes and swabs.
$250.99
Retatrutide Pen Kit (15mg)
15mg premixed retatrutide pen with twenty pen needles and swabs. Nothing to mix.
$235.99
In this kit
Frequently bought together
Bacteriostatic Water 10mL
Sterile water with 0.9% benzyl alcohol for reconstituting lyophilised peptides. Enough for every single- and two-vial kit.
$19.99
Insulin Syringes 20 pack
U-100 1 mL insulin syringes with fixed 29–31G needle, pack of 20, for measuring reconstituted solution.
$19.99
